Filing Details

Accession Number:
0001213900-25-091105
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-09-24 16:01:57
Reporting Period:
2025-09-22
Filing Date:
2025-09-24
Accepted Time:
2025-09-24 16:01:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1788028 Jasper Therapeutics Inc. JSPR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208907 G Thomas Wiggans C/O Jasper Therapeutics, Inc.
2200 Bridge Pkwy, Suite #102
Redwood City CA 94065
Yes No No No
Transaction Summary
Purchased: 41,000 shares Avg. Price: $2.43 Total Value: $99,630.00
Number of Shares After Transactions: 41,000 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Acquisiton 2025-09-22 41,000 $2.43 41,000 No 4 P Indirect By Wiggans Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Wiggans Living Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Voting Common Stock Common Stock Warrant (right to buy) Acquisiton 2025-09-22 41,000 $0.00 41,000 $2.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
41,000 2026-03-22 2030-03-22 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Voting Common Stock 5,000 Direct
Footnotes
  1. Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.